Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSTR Technique Modifications in Primary Second Molars
NCT07836686Completed
- Sponsor
- Uşak University
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised trial of metronidazole, ciprofloxacin + ibuprofen gel and clindamycin in pulp necrosis and irreversible pulpitis (4 arms), sponsored by Uşak University. Primary endpoints: Clinical Success of LSTR Treatment at 12 months, Radiographic Success of LSTR Treatment at 12 months and 1 more. Started Nov 2024; status: completed.
02
Drugs
metronidazoleciprofloxacin + ibuprofen gelclindamycin
03
Conditions
pulp necrosisirreversible pulpitis
Beyond the preview
Go deeper on NCT07836686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836686.